Bone Therapeutics
Bone Therapeutics, a Belgian biotechnology company established in 2006, specializes in developing innovative cell therapy products to treat orthopedic conditions and bone diseases. Its flagship product, ALLOB, is an allogeneic cell therapy currently in Phase II trials for delayed-union fractures and spinal fusion.
Top Stages
1 past transactions
Medsenic
Acquisition in 2022
Medsenic SAS is a privately held company based in Paris, France, specializing in the development and manufacture of drugs aimed at treating autoimmune diseases, including systemic lupus erythematosus and graft-versus-host disease. Founded in 2010, the company also produces arsenic trioxide, which is utilized in the treatment of acute promyelocytic leukemia, contributing to significant remissions and potential cures for serious conditions. Medsenic focuses on innovative therapeutic solutions to address unmet medical needs in the field of autoimmune and hematological disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.